Copy to clipboard 
Within hours in late January, Stryker announced the divestiture of its spine implant business to VB Spine, a Viscogliosi Brothers company, and Zimmer Biomet stated its intention to add Paragon 28 to expand its foot and ankle business.
Medacta acquired Parcus Medical from Anika Therapeutics to build upon its sports medicine portfolio. Globus Medical intends to enter the interventional spine space with its purchase of NevRo.
In February, Medtronic acquired some aspects of Nanovis’ FDA-designated bone-growth nanotechnology, which has been shown to improve the speed and consistency of the human bone-growth response.
The magnitude of the deals stand in stark contrast to the low levels of M&A activity in recent years and have changed the outlook of some of the major players within the orthopedic industry.
ORTHOWORLD reports that deal volume fell by nearly 30% between 2021 and 2024 to 110 total transactions, with spine accounting for nearly a quarter of the transactions. In contrast, deals associated with orthobiologics and digital technology increased significantly to 20% and 19%, respectively. According to ORTHOWORLD estimates, spine M&A will decline over the remainder of the year while digital technology deals continue to increase.
Infographic proudly sponsored by Orchid Orthopedic Solutions.
